PTC Therapeutics, Inc. (PTCT)
Nasdaq: PTCT · Pharmaceutical Preparations · Warren, NJ · filing with the SEC since 2004
Grade6.3
◀ Past 6.9● Present 5.8▶ Future 6.4
Who runs PTC Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Klein Matthew B.
CHIEF EXECUTIVE OFFICER. First filing Apr 2020, latest Aug 6, 2026, 27 filings in all.
Officers reporting now
7
of 18 people with a filing in the last fifteen months
Directors reporting now
11
30 people on the record since 2013
Officerssales are open-market, Oct 16, 2025 to Oct 16, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Boulding Mark Elliott | EXEC. VP AND CLO | Jun 2013 | Oct 13, 2026 | 52 · $4.2M |
| Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Apr 2020 | Aug 6, 2026 | 13 · $4.2M |
| Gravier Pierre | CHIEF FINANCIAL OFFICER | Jul 2023 | Jul 16, 2026 | 3 · $700,000 |
| Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Jun 2013 | Jul 13, 2026 | 56 · $22.4M |
| Utter Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | Jun 2017 | Jun 22, 2026 | 5 · $1.9M |
| Pauwels Eric | CHIEF BUSINESS OFFICER | Apr 2020 | Jun 12, 2026 | 28 · $7.5M |
| Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | Jun 2023 | Apr 6, 2026 | 6 · $1.1M |
Directorssales are open-market, Oct 16, 2025 to Oct 16, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Schmertzler Michael | director | Jun 2013 | Oct 16, 2026 | 20 · $6.6M |
| Steele Glenn Jr Md Phd | director | Jun 2015 | Oct 2, 2026 | 2 · $1.7M |
| Sollie-Zetlmayer Hege Elisabeth | director | Jul 2026 | Jul 30, 2026 | none |
| Smith Mary L. | director | Jun 2021 | Jul 13, 2026 | 2 · $1.4M |
| Chutter Jessica Caroline | director | Mar 2026 | Mar 26, 2026 | none |
| Okey Stephanie | director | Dec 2018 | Mar 12, 2026 | 3 · $1.5M |
| Jacobson Allan Steven | director | Jun 2013 | Jan 6, 2026 | 10 · $2.1M |
| Reeve Emma | director | Dec 2018 | Jan 6, 2026 | 6 · $2.5M |
| Southwell David P | director | Jun 2013 | Jan 6, 2026 | none |
| Young Alethia | director | Jun 2022 | Jan 6, 2026 | none |
| Zeldis Jerome B | director | Jun 2013 | Jan 6, 2026 | none |
Earlier names on the record13, newest filing first
Bell William F. Jr. · director · last filing Feb 2024Hill Emily Luisa · officer · last filing Mar 2023Peltz Stuart Walter · officer · last filing Feb 2023Svoronos Dawn · director · last filing Jun 2022Souza Marcio · officer · last filing Feb 2020Rothera Mark · officer · last filing May 2017Kovacs Shane William Charles · officer · last filing May 2017Complete Pharma Holdings II, LLC · 10% owner · last filing May 2017Ong Tuyen · officer · last filing Jan 2017Koppel Adam · director · last filing Jan 2017Mcdonough Cameron Geoffrey · director · last filing Jan 2017Renaud Ronald C Jr · director · last filing Jan 2017Spiegel Robert J. · officer · last filing Jan 2016
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.